Dissemin is shutting down on January 1st, 2025

Published in

National Academy of Sciences, Proceedings of the National Academy of Sciences, 22(107), p. 10160-10165, 2010

DOI: 10.1073/pnas.0913745107

Links

Tools

Export citation

Search in Google Scholar

Peptide antagonism as a mechanism for NK cell activation

Journal article published in 2010 by Lena Fadda, Gwenoline Borhis, Parvin Ahmed, Kuldeep Cheent, Sophie V. Pageon ORCID, Angelica Cazaly, Stavros Stathopoulos, Derek Middleton, Arend Mulder, Frans H. J. Claas, Tim Elliott, Daniel M. Davis, Marco A. Purbhoo, Salim I. Khakoo
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Inhibition of natural killer (NK) cells is mediated by MHC class I receptors including the killer cell Ig-like receptor (KIR). We demonstrate that HLA-C binding peptides can function as altered peptide ligands for KIR and antagonize the inhibition mediated by KIR2DL2/KIR2DL3. Antagonistic peptides promote clustering of KIR at the interface of effector and target cells, but do not result in inhibition of NK cells. Our data show that, as for T cells, small changes in the peptide content of MHC class I can regulate NK cell activity.